ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,408.90
0.36%
S&P ASX All Technology
3,893.00
0.20%
Brent Oil
77.625
0.00%
US Dollar vs AUD
1.58353
0.00%
Bitcoin
104,613.55
-0.23%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. CureVac NV (CVAC) Share Price

CureVac NV

CureVac NV (CVAC)

NASDAQ
3.85
-0.11
(-2.78%)
Closed 26 January 8:00AM
Delayed by 15 minutes
3.82
-0.03
(-0.78%)
After Hours: 11:52AM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
3.82
Bid
3.39
Offer
4.45
Volume
724,222
3.815 Day's Range 4.0782
2.215 52 Week Range 5.28
Market Cap
855.637M
Previous Close
3.96
Open
4.002
Last Trade
50
@
3.8
Last Trade Time
Financial Volume
US$ 2,847,367
VWAP
3.9316
Average Volume (3m)
806,308
Shares Outstanding
223,988,675
Dividend Yield
-
PE Ratio
-3.31
Earnings Per Share (EPS)
-1.16
Revenue
61.71M
Net Profit
-260.17M

About CureVac NV

CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid (mRNA). The company was founded in 2000 and had its initial public offering in August 2020. CureVac is collaborating with GlaxoSmithKline to develop a second-gen... CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid (mRNA). The company was founded in 2000 and had its initial public offering in August 2020. CureVac is collaborating with GlaxoSmithKline to develop a second-generation COVID-19 vaccine. CureVac's first attempt to develop a COVID-19 vaccine did not have sufficient efficacy data, and its trials were discontinued in October 2021. The company's other pipeline candidates include mRNA vaccines for influenza, rabies, and malaria. Additionally, CureVac is in the early stages of development for oncology and molecular therapies spanning tumors, liver, ocular, and lung diseases. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.curevac.com
Headquarters
Tubingen, Deu
Founded
-
CureVac NV is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CVAC. The last closing price for CureVac NV was US$3.96. Over the last year, CureVac NV shares have traded in a share price range of US$ 2.215 to US$ 5.28.

CureVac NV currently has 223,988,675 shares in issue. The market capitalisation of CureVac NV is US$887 million. CureVac NV has a price to earnings ratio (PE ratio) of -3.31.

Ask ADVFN Intelligence (AI)

CVAC Latest News

More News

Form 144 - Report of proposed sale of securities

08 January 2025
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

08 January 2025
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

08 January 2025
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

08 January 2025
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

13 November 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

13 November 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

05 November 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

05 November 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

28 September 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

26 September 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.37-8.830548926014.194.33.75996654104.07315954CS
40.7424.0259740263.0853.031713696034.13160587CS
121.0437.41007194242.7852.378063083.48855289CS
260.174.657534246583.6552.376223943.34851998CS
520.12.688172043013.725.282.2158429213.42871924CS
156-14.18-78.77777777781820.62.2157344357.45958538CS
260-81.17-95.50535357184.991332.21579972132.35620175CS

CVAC - Frequently Asked Questions (FAQ)

What is the current CureVac NV share price?
The current share price of CureVac NV is US$ 3.82
How many CureVac NV shares are in issue?
CureVac NV has 223,988,675 shares in issue
What is the market cap of CureVac NV?
The market capitalisation of CureVac NV is USD 887M
What is the 1 year trading range for CureVac NV share price?
CureVac NV has traded in the range of US$ 2.215 to US$ 5.28 during the past year
What is the PE ratio of CureVac NV?
The price to earnings ratio of CureVac NV is -3.31
What is the cash to sales ratio of CureVac NV?
The cash to sales ratio of CureVac NV is 13.97
What is the reporting currency for CureVac NV?
CureVac NV reports financial results in EUR
What is the latest annual turnover for CureVac NV?
The latest annual turnover of CureVac NV is EUR 61.71M
What is the latest annual profit for CureVac NV?
The latest annual profit of CureVac NV is EUR -260.17M
What is the registered address of CureVac NV?
The registered address for CureVac NV is FRIEDRICH-MIESCHER-STRASSE 15, TUBINGEN, 72076
What is the CureVac NV website address?
The website address for CureVac NV is www.curevac.com
Which industry sector does CureVac NV operate in?
CureVac NV operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NVNINVNI Group Ltd
US$ 4.38
(193.96%)
366.98M
EVAXEvaxion Biotech AS
US$ 5.99
(64.56%)
55.41M
ELABPMGC Holdings Inc
US$ 3.0901
(56.07%)
76.48M
PCLAPicoCELA Inc
US$ 4.60
(49.35%)
3.75M
GOEVCanoo Inc
US$ 0.475
(43.94%)
282.22M
GODNUGolden Star Acquisition Corporation
US$ 3.11
(-75.82%)
17.51k
GODNGolden Star Acquisition Corporation
US$ 2.93
(-65.67%)
902.76k
NXTTNext Technology Holding Inc
US$ 1.37
(-54.93%)
2.56M
SGLYSingularity Future Technology Ltd
US$ 1.625
(-38.45%)
917.77k
WHLRLWheeler Real Estate Investment Trust Inc
US$ 90.11
(-38.07%)
8
ACONAclarion Inc
US$ 0.0557
(28.94%)
811.91M
NVNINVNI Group Ltd
US$ 4.38
(193.96%)
366.98M
RIMEAlgorhythm Holdings Inc
US$ 0.0357
(4.69%)
284.97M
GOEVCanoo Inc
US$ 0.475
(43.94%)
282.22M
NVDANVIDIA Corporation
US$ 142.62
(-3.12%)
232.88M

CVAC Discussion

View Posts
TrendTrade2016 TrendTrade2016 2 months ago
CVAC IN HERE...WHAT A BALANCE SHEET
👍️0
Monksdream Monksdream 5 months ago
CVAC under $4
👍️0
tw0122 tw0122 8 months ago
There is a cure again
👍️0
Monksdream Monksdream 9 months ago
CVAC new 52 week low
👍️0
Monksdream Monksdream 9 months ago
CVAC new 52 week low
👍️0
Monksdream Monksdream 11 months ago
CVAC new 52 week low
👍️0
Monksdream Monksdream 11 months ago
CVAC new 52 week low
👍️0
mick mick 1 year ago
https://www.otcmarkets.com/stock/CVAC
👍️0
mick mick 1 year ago
https://www.otcmarkets.com/stock/CVAC
👍️0
mick mick 1 year ago
https://www.otcmarkets.com/stock/CVAC
👍️0
mick mick 1 year ago
https://www.otcmarkets.com/stock/CVAC
👍️0
mick mick 1 year ago
https://www.otcmarkets.com/stock/CVAC
👍️0
mick mick 1 year ago
CVAC
CureVac NV
8.99
0.09 (1.01%)
Volume: 232,857
Day Range: 8.73 - 9.15
Last Trade Time: 6:30:54 PM EDT
👍️0
Mr. Pearson Mr. Pearson 2 years ago
Big News coming soon... just be patient....
👍️0
mick mick 2 years ago
CVAC
CureVac NV
10.98
1.30 (13.43%)
Volume: 464,848
Day Range: 9.72 - 10.47
Last Trade Time: 7:53:28 PM EDT
👍️0
mick mick 2 years ago
CVAC
CureVac NV
10.98
1.30 (13.43%)
Volume: 464,848
Day Range: 9.72 - 10.47
Last Trade Time: 7:53:28 PM EDT
👍️0
mick mick 2 years ago
CVAC
CureVac NV
10.98
1.30 (13.43%)
Volume: 464,848
Day Range: 9.72 - 10.47
Last Trade Time: 7:53:28 PM EDT
👍️0
mick mick 2 years ago
CVAC
CureVac NV
12.23
0.80 (7.00%)
Volume: 2,433,695
Day Range: 11.02 - 12.36
Last Trade Time: 7:59:28 PM EDT
👍️0
mick mick 2 years ago
CVAC
CureVac NV
12.23
0.80 (7.00%)
Volume: 2,433,695
Day Range: 11.02 - 12.36
Last Trade Time: 7:59:28 PM EDT
👍️0
mick mick 2 years ago
CVAC
CureVac NV
9.15
-0.28 (-2.97%)
Volume: 373,244
Day Range: 9.06 - 9.49
Last Trade Time: 6:38:15 PM EDT
👍️0
mick mick 2 years ago
CVAC
CureVac NV
7.37
0.05 (0.68%)
Volume: 613,302
Day Range: 7.28 - 7.40
Last Trade Time: 7:50:44 PM EDT
👍️0
mick mick 2 years ago
CVAC
CureVac NV
7.79
-0.11 (-1.39%)
Volume: 227,150
Day Range: 7.66 - 8.13
Last Trade Time: 5:09:42 PM EDT
👍️0
mick mick 2 years ago
CVAC
CureVac NV
7.79
-0.11 (-1.39%)
Volume: 227,150
Day Range: 7.66 - 8.13
Last Trade Time: 5:09:42 PM EDT
👍️0
mick mick 2 years ago
CVAC
CureVac NV
7.79
-0.11 (-1.39%)
Volume: 227,150
Day Range: 7.66 - 8.13
Last Trade Time: 5:09:42 PM EDT
👍️0
mick mick 2 years ago
CVAC
CureVac NV
7.79
-0.11 (-1.39%)
Volume: 227,150
Day Range: 7.66 - 8.13
Last Trade Time: 5:09:42 PM EDT
👍️0
mick mick 2 years ago
CVAC
CureVac NV
8.50
-0.16 (-1.85%)
Volume: 641,450
Day Range: 8.52 - 8.68
Last Trade Time: 7:00:46 PM EST
👍️0
mick mick 2 years ago
CVAC
CureVac NV
11.06
-0.62 (-5.31%)
Volume: 537,147
Day Range: 11.01 - 11.83
Last Trade Time: 7:55:22 PM EST
👍️0
mick mick 2 years ago
it is relative CureVac (CVAC) Receives a Buy from Berenberg Bank
August 23 2022 - 09:55PM
TipRanks
Alert
Print
Share On Facebook
In a report released yesterday, Zhiqiang Shu from Berenberg Bank maintained a Buy rating on CureVac (CVAC - Research Report), with a price target of $45.00. The company's shares closed yesterday at $11.32.Shu covers the Healthcare sector, focusing on stocks such as Alnylam Pharma, Arcus Biosciences, and Sutro Biopharma. According to TipRanks, Shu has an average return of -21.0% and a 23.78% success rate on recommended stocks. Currently, the analyst consensus on CureVac is a Moderate Buy with an average price target of $28.50, implying a 151.77% upside from current levels.
https://www.tipranks.com/news/blurbs/curevac-cvac-receives-a-buy-from-berenberg-bank?utm_source=advfn.com&utm_medium=referral
👍️0
mick mick 2 years ago
CVAC
CureVac NV
6.60
-0.21 (-3.08%)
Volume: 387,429
Day Range: 6.58 - 6.99
Last Trade Time: 4:09:13 PM EST
👍️0
mick mick 2 years ago
i think $CVAC is ah buyout candidate /\

let's say $40
👍️0
mick mick 2 years ago
CVAC
CureVac NV
6.81
0.04 (0.59%)
Volume: 1,065,479
Day Range: 6.52 - 6.93
Last Trade Time: 4:46:47 PM EST
👍️0
mick mick 2 years ago
CVAC
CureVac NV
7.49
0.28 (3.88%)
Volume: 181,787
Day Range: 7.155 - 7.49
Bid: 6.13
Ask: 9.18
Last Trade Time: 4:13:18 PM EDT
Total Trades: 1,819
CVAC Detailed Quote
👍️0
mick mick 2 years ago
CVAC
CureVac NV
7.49
0.28 (3.88%)
Volume: 181,787
Day Range: 7.155 - 7.49
Bid: 6.13
Ask: 9.18
Last Trade Time: 4:13:18 PM EDT
Total Trades: 1,819
CVAC Detailed Quote
👍️0
mick mick 2 years ago
CVAC
CureVac N.V.
Ordinary Shares
9.84
-0.40

-3.90%

Delayed (15 Min) Trade Data: 04:00pm 08/31/2022
Overview
Quote
Company Profile
Security Details
News
Financials
Disclosure
Research
👍️0
mick mick 2 years ago
we don't show quote ?????
👍️0
mick mick 2 years ago
we don't show quote ?????
👍️0
mick mick 2 years ago
CureVac (CVAC) Receives a Buy from Berenberg Bank
August 23 2022 - 09:55PM
TipRanks
Alert
Print
Share On Facebook
In a report released yesterday, Zhiqiang Shu from Berenberg Bank maintained a Buy rating on CureVac (CVAC - Research Report), with a price target of $45.00. The company's shares closed yesterday at $11.32.Shu covers the Healthcare sector, focusing on stocks such as Alnylam Pharma, Arcus Biosciences, and Sutro Biopharma. According to TipRanks, Shu has an average return of -21.0% and a 23.78% success rate on recommended stocks. Currently, the analyst consensus on CureVac is a Moderate Buy with an average price target of $28.50, implying a 151.77% upside from current levels.
https://www.tipranks.com/news/blurbs/curevac-cvac-receives-a-buy-from-berenberg-bank?utm_source=advfn.com&utm_medium=referral
👍️0
mick mick 3 years ago
CVAC
CureVac NV
12.62
-0.03 (-0.24%)
Volume: 276,718
Day Range: 12.39 - 12.79
Bid: 12.60
Ask: 13.18
Last Trade Time: 4:57:18 PM EDT
Total Trades: 3,775
CVAC Detailed Quote
👍️0
sdy sdy 3 years ago
Interesting new Beneficial Owners recently. Taken an entry position today.
Looks like Covid-19 vaccines still hold prominent place in biotech research: "CureVac and GSK's second-generation vaccine candidate targeting two recent COVID-19 variants has been shown to be highly effective in preclinical studies on mice, CureVac said, as it seeks to catch up with rivals' development work." https://finance.yahoo.com/news/1-curevac-gsks-experimental-covid-124419805.html
👍️0
mick mick 3 years ago
CureVac NV (CVAC)
18.18 ? -0.65 (-3.45%)
Volume: 402,327 @06/03/22 6:58:05 PM EDT
Bid Ask Day's Range
17.61 20.1 17.56 - 18.58
CVAC Detailed Quote
👍️0
mick mick 3 years ago
CureVac NV (CVAC)
18.18 ? -0.65 (-3.45%)
Volume: 402,327 @06/03/22 6:58:05 PM EDT
Bid Ask Day's Range
17.61 20.1 17.56 - 18.58
CVAC Detailed Quote
👍️0
mick mick 3 years ago
https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-contrafect-cfrx-curevac-cvac?utm_source=advfn.com&utm_medium=referral
👍️0
mick mick 3 years ago
https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-contrafect-cfrx-curevac-cvac?utm_source=advfn.com&utm_medium=referral
👍️0
mick mick 3 years ago
CureVac NV (CVAC)
17.205 ? 0.625 (3.77%)
Volume: 164,845 @04/29/22 1:27:43 PM EDT
Bid Ask Day's Range
17.2 17.25 16.47 - 17.44
CVAC Detailed Quote
👍️0
mick mick 3 years ago
CureVac NV (CVAC)
15.69 ? -1.08 (-6.44%)
Volume: 305,719 @03/11/22 5:11:50 PM EST
Bid Ask Day's Range
15.7 16.66 15.68 - 17.225
CVAC Detailed Quote
👍️0
mick mick 3 years ago
CureVac NV (CVAC)
18.19 ? 0.05 (0.28%)
Volume: 587,579 @02/04/22 5:09:58 PM EST
Bid Ask Day's Range
17.05 19.74 17.7685 - 18.61
CVAC Detailed Quote
👍️0
mick mick 3 years ago
https://www.otcmarkets.com/stock/CVAC
👍️0
mick mick 3 years ago
https://www.otcmarkets.com/stock/CVAC
👍️0
2times2 2times2 3 years ago
CureVac Says Preclinical Trial Shows Antibody Levels of COVID-19 Vaccine Candidate CV2CoV 'Highly Comparable' With Pfizer's mRNA Vaccine
MT NEWSWIRES 3:11 PM ET 11/18/2021

03:11 PM EST, 11/18/2021 (MT Newswires) -- CureVac(CVAC) said Thursday the extended preclinical study of the second-generation vaccine candidate, CV2CoV, showed that neutralizing antibody levels after full vaccination of animals were "highly comparable" with Pfizer (PFE) and BioNTech's (BNTX) licensed mRNA vaccine, Comirnaty.

CureVac (CVAC) is developing CV2CoV in partnership with GlaxoSmithKline (GSK). Animals were vaccinated with either 12 micrograms of CV2CoV or a 30 microgram standard dose of Comirnaty.

Data showed that targeted optimizations of a non-chemically modified mRNA can significantly improve immune responses in a preclinical model.

👍️0
mick mick 3 years ago
CureVac NV (CVAC)
38.0 ? -3.47 (-8.37%)
Volume: 1,621,942 @11/05/21 7:55:54 PM EDT
Bid Ask Day's Range
38.02 38.19 36.32 - 39.33
CVAC Detailed Quote
👍️0

Your Recent History

NASDAQ
CVAC
CureVac NV
BIT
F08958
Vontobel Financial Produ...
BOV
PASS6T
Compass Gas E Energia
BIT
F25255
Vontobel Financial Produ...
BIT
PWS
Powersoft
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads